Clinical Trials Browser

Gastroesophageal Cancer

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Squamous Cell Carcinoma of Head and Neck

Anus Neoplasms

Pathologic Complete Response, Rectal Neoplasms

Esophageal Squamous Cell Carcinoma

Breast Neoplasms, Triple Negative Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Pancreatic Cancer Metastatic

Nasopharyngeal Carcinoma

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasms, Disease Progression

Carcinoma, Non-Small-Cell Lung

Urinary Bladder Neoplasms

Lung Neoplasms

Uterine Cervical Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Rectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Breast Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Mesothelioma, Malignant, Mesothelioma

Pancreatic Neoplasms

Triple Negative Breast Neoplasms

Recurrence, Stomach Neoplasms

Locally Advanced Pancreatic Adenocarcinoma

Leukemia, Myeloid, Acute

Carcinoma, Non-Small-Cell Lung

Adebrelimab (SHR-1316)

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular

Breast Neoplasms

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

Ovarian Neoplasms

Limited Stage Small Cell Lung Cancer

Resectable Non-small Cell Lung Cancer

Colorectal Neoplasms

Triple Negative Breast Neoplasms

Carcinoma, Squamous Cell, Esophageal Neoplasms

Muscle-invasive Bladder Cancer

Osteosarcoma

Meningeal Carcinomatosis

Clinical Trials

HER-OIC

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

GIVEN

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

TD-NEOE3V3

FACT-TN

Lattice-Based Radiotherapy and Chemo-Immunotherapy for Oral Cavity Squamous Cell Carcinoma

Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy

TD-ENSEMBLE

Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

PACHA-02

HYPERBOLIC

A Phase 2 Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.

Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer

AssiutU

Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial

REFIRT

[18F]-AraG PET Imaging in LA HNSCC

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

Iparomlimab and Tuvonralimab Plus Chemotherapy for Inducing Conversion to Resectability in Initially Unresectable Stage III NSCLC

PRIME-Lung

QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer

A Randomized Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC).

Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery

RAIPANC

Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?

Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC

Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC

Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

DARTS

SENIOR

OMEC-5

SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer

Neoadjuvant

LICoRN-01

Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W

PTMTO

Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs